Association Study of Serine Racemase Gene with Methamphetamine Psychosis
Open Access
- 1 March 2011
- journal article
- Published by Bentham Science Publishers Ltd. in Current Neuropharmacology
- Vol. 9 (1) , 169-175
Abstract
Experimental studies have demonstrated that not only dopaminergic signaling but also glutamatergic/NMDA receptor signaling play indispensable roles in the development of methamphetamine psychosis. Our recent genetic studies provided evidence that genetic variants of glutamate-related genes such as DTNBP1, GLYT1, and G72, which are involved in glutamate release and regulation of co-agonists for NMDA receptors, conferred susceptibility to methamphetamine psychosis. Serine racemase converts l-serine to d-serine, which is an endogenous co-agonist for NMDA receptors. Three single nucleotide polymorphisms (SNPs) in the promoter region of the serine racemase gene (SRR), rs224770, rs3760229, and rs408067, were proven to affect the transcription activity of SRR. Therefore, we examined these SNPs in 225 patients with methamphetamine psychosis and 291 age- and sex-matched controls. There was no significant association between methamphetamine psychosis and any SNP examined or between the disorder and haplotypes comprising the three SNPs. However, rs408067 was significantly associated with the prognosis for methamphetamine psychosis and multi-substance abuse status. The patients with C-positive genotypes (CC or CG) of rs408067 showed better prognosis of psychosis after therapy and less abuse of multiple substances than the patients with GG genotypes. Because the C allele of rs408067 reduces the expression of SRR, a lower d-serine level or reduced NMDA receptor activation may affect the prognosis of methamphetamine psychosis and multiple substance abuse. Our sample size is, however, not large enough to eliminate the possibility of a type I error, our findings must be confirmed by replicate studies with larger samples.Keywords
This publication has 28 references indexed in Scilit:
- Quite a lot of smoke but very limited fire—the use of methamphetamine in EuropeDrug and Alcohol Review, 2008
- The Dysbindin Gene (DTNBP1) Is Associated with Methamphetamine PsychosisBiological Psychiatry, 2008
- Clinical Features of Sensitization to Methamphetamine Observed in Patients with Methamphetamine Dependence and PsychosisAnnals of the New York Academy of Sciences, 2004
- Characterization and localization of a human serine racemaseMolecular Brain Research, 2004
- Nine- or fewer repeat alleles in VNTR polymorphism of the dopamine transporter gene is a strong risk factor for prolonged methamphetamine psychosisThe Pharmacogenomics Journal, 2003
- Altered responsiveness of medial prefrontal cortex neurons to glutamate and dopamine after withdrawal from repeated amphetamine treatmentSynapse, 2000
- Amphetamine‐Induced Glutamate Efflux in the Rat Ventral Tegmental Area Is Prevented by MK‐801, SCH 23390, and Ibotenic Acid Lesions of the Prefrontal CortexJournal of Neurochemistry, 1999
- Increased Responsiveness of Ventral Tegmental Area Dopamine Neurons to Glutamate after Repeated Administration of Cocaine or Amphetamine Is Transient and Selectively Involves AMPA ReceptorsThe Journal of Pharmacology and Experimental Therapeutics, 1997
- Acute and Repeated Systemic Amphetamine Administration: Effects on Extracellular Glutamate, Aspartate, and Serine Levels in Rat Ventral Tegmental Area and Nucleus AccumbensJournal of Neurochemistry, 1996
- Blockade of “reverse tolerance” to cocaine and amphetamine by MK-801Life Sciences, 1989